Gumda, Mohammad .
HRN: 14-86-72 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2025
CO-AMOXICLAV 625MG (TAB)
05/08/2025
05/15/2025
PO
625mg
Tid
CAP LR
Waiting Final Action
05/11/2025
CEFIXIME 200MG (CAP)
05/11/2025
05/18/2025
ORAL
1 Tab
BID
CAP LR
Waiting Final Action